TGEN Form 4: Director Ahmed Ghoniem Receives 25K Option Grant

Rhea-AI Filing Summary

Form 4 filing for Tecogen Inc. (TGEN) discloses that director Ahmed Ghoniem received a new equity award on 24 Jul 2025.

• Security: Non-qualified stock option granting the right to purchase 25,000 common shares.
• Exercise price: $8.35 per share.
• Vesting: 25 % annually (fully vested after four years, per footnote 1).
• Expiration: 24 Jul 2035, giving a 10-year term after the first vesting date.
• Post-grant holdings: Filing shows 237,723 derivative securities held directly (includes the new option).
• Role: Ghoniem is marked as a Director; no change in status or control is indicated.

The transaction is classified under code “A” (grant) and represents routine director compensation rather than an open-market purchase or sale. No non-derivative share activity or cash proceeds are reported, and no other executives are listed. Financial performance metrics, earnings data, or guidance are not included in this filing.

Positive

• Equity alignment: New 25,000-share option grant ties director compensation to future stock performance, potentially aligning interests with shareholders.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine director option grant; neutral impact, but modest alignment with shareholders.

The 25 k share option awarded to Director Ghoniem is standard equity compensation. At $8.35 strike, value depends on future price appreciation; investors gain modest comfort that the director’s incentives hinge on long-term share performance. However, the grant does not signal insider conviction through open-market buying, nor does it affect share count today. Material impact on valuation or near-term liquidity is negligible.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

GHONIEM AHMED

(Last) (First) (Middle)

99 HIGH ST.

(Street)

WINCHESTER MA 01890

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TECOGEN INC. [ TGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$8.35	07/24/2025		A		25,000		07/24/2026(1)	07/24/2035	Common Stock	25,000	$8.35	237,723	D

Explanation of Responses:

1. Vests 25% per year

Remarks:

	/s/ Ahmed Ghoniem	07/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Tecogen (TGEN) report on 24 Jul 2025?

Director Ahmed Ghoniem received a stock option for 25,000 shares at an $8.35 exercise price.

How does the option granted to Ahmed Ghoniem vest?

The filing states it vests 25 % per year, reaching full vesting after four years.

When will the new Tecogen options expire?

The expiration date is 24 Jul 2035, ten years after the first vesting anniversary.

Did the Tecogen Form 4 include any open-market share purchases or sales?

No. The only reported transaction is an option grant; no shares were bought or sold.

What is Ahmed Ghoniem’s total derivative ownership after the grant?

The form lists 237,723 derivative securities held directly following the reported transaction.